Long-term outcome of pancreatic function following oncological surgery in children: Institutional experience and review of the literature

Table 1 Our scheduled follow-up for pancreatic neoplasms after surgery in children

	T1	T2	T3
Clinical examination (physical examination, symptoms, weight, height, BMI)	Every 4 mo	Every 6 mo	Once a year
Routine lab tests (CBC, liver and kidney function tests, amylase, lipase, bilirubin, albumin, etc.)	Every 4 mo	Every 6 mo	Once a year
Vitamin dosage (A, D, E, clotting test)	Every 4 mo	Every 6 mo	Once a year
Serological markers (according to the underlying histology) (alpha-FP, Chromogranin-A)	Every 4 mo	Every 6 mo	Once a year
Assessment of exocrine pancreatic function (fecal elastase)	Every 4 mo	Every 6 mo	Once a year
Assessment of endocrine pancreatic function (fasting blood glucose, glycated hemoglobin, C-peptide)	Every 4 mo	Every 6 mo	Once a year
Imaging (abdominal US)	Every 4 mo	Every 6 mo	Once a year
Surgical, diabetological and oncological consulting	Every 4 mo	Every 6 mo	Once a year
Nutritional assessment (3-d recall dietary assessment and diet optimization by dietitians)	Every 4 mo	Every 6 mo	Once a year

T1: First year after diagnosis; T2: Second year after diagnosis; T3: Third year to 10 yr after diagnosis (end of follow-up); BMI: Body mass index; CBC: Complete blood count; alpha-FP: alpha-Fetoprotein; US: Ultrasound.